To verify this, we detected the expression level of IκBα in HCC cells treated with proteasome inhibitor MG132 and found that IκBα protein was not affected by COMMD10 deficiency or overexpression compared to corresponding control cells (Figures 2C and 2D). This evidence concerns the gene COMMD10 and hepatocellular carcinoma.